Adding further evidence that life sciences transport is “the new black” in the global transportation business, UPS has entered into a “definitive purchase agreement” to acquire Marken, A U.K.-based supply-chain company focusing on pharmaceuticals and life sciences.
UPS plans to use Marken’s clinical supply-chain services to bolster its position across the life sciences market, and plans to close the deal – subject to customary conditions and regulatory approvals – by Dec. 31 of this year. “He…
This content is for currently subscribed users only.
To get access to all premium content and continue reading, subscribe to Air Cargo World for FREE.
Subscribe to Air Cargo World
I already have a subscription, LOGIN
Login
Source: aircargoworld